Skip to main content

Cardiovascular disorders


Browse the latest news, expert commentary, and educational content on cardiovascular disorders.


Highlights

Human heart with ecg graph. 3d illustration

11-18-2022 | Dapagliflozin | News

Dapagliflozin HFpEF benefits independent of glucose levels

People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.

Human kidney cross section

11-08-2022 | SGLT2 inhibitors | News

Meta-analysis backs SGLT2 inhibitors for kidney disease

A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.

Cardiovascular event - symbolic image

10-21-2022 | Cardiovascular disorders | News

Diabetes ‘no longer a CVD risk equivalent’

The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox